Zimmer Biomet
868 hedge funds and large institutions have $20B invested in Zimmer Biomet in 2018 Q2 according to their latest regulatory filings, with 64 funds opening new positions, 286 increasing their positions, 324 reducing their positions, and 64 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
0.36% less ownership
Funds ownership: 91.1% → 90.74% (-0.36%)
1% less funds holding
Funds holding: 874 → 868 (-6)
12% less repeat investments, than reductions
Existing positions increased: 286 | Existing positions reduced: 324
Holders
868
Holding in Top 10
12
Calls
$87M
Puts
$56.3M
Top Buyers
| 1 | +$318M | |
| 2 | +$132M | |
| 3 | +$81.9M | |
| 4 |
KP
Kiltearn Partners
Edinburgh,
United Kingdom
|
+$70.1M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$68.7M |
Top Sellers
| 1 | -$228M | |
| 2 | -$87.5M | |
| 3 | -$61.5M | |
| 4 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$58.8M |
| 5 |
Two Sigma Advisers
New York
|
-$54.6M |